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Abstract
Background: Twenty common genetic variants have been associated with risk of developing colorectal cancer
(CRC) in genome wide association studies to date. Since large differences between populations exist, generalisability
of findings to any specific population needs to be confirmed.
Aim: The aim of this study was to perform an association study between risk variants: rs10795668, rs16892766,
rs3802842 and rs4939827 and CRC risk in Croatian population.
Methods: An association study was performed on 320 colorectal cancer cases and 594 controls recruited in Croatia.
We genotyped four variants previously associated with CRC: rs10795668, rs16892766, rs3802842 and rs4939827.
Results: SMAD7 variant rs4939827 (18q21.1) was significantly associated with CRC risk in Croatian population. C
allele was associated with a decreased risk, odds ratio (OR): 0.70 (95% CI: 0.57-0.85, P=3.5E-04). Compared to TT
homozygotes, risk was reduced by 34% in heterozygotes (OR=0.66, 95% CI: 0.47-0.92) and by 52% in CC
homozygotes (OR=0.48, 95% CI: 0.33-0.72).
Conclusion: Our results show association of rs4939827 with colorectal cancer risk in Croatian population. The
higher strength of the association in comparison to other studies suggests population-specific environmental or
genetic factors may be modifying the association. More studies are needed to further describe role of rs4939827 in
CRC. Likely reason for failure of replication for other 3 loci is inadequate study power.
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Introduction
Colorectal cancer (CRC) affects over one million people
worldwide each year [1]. It is the third most common cancer
and fourth leading cause of cancer mortality [2]. Whilst
colorectal cancer mortality has been declining over the last two
decades in Europe [3], an increase in both mortality and
incidence has been reported for Croatia [4]. When compared to
other European countries, Croatia is ranked 4th for mortality in
both men (age-standardised rate, ASR: 25.4/100,000) and
women (ASR: 13.1/100,000), but according to CRC incidence it
is ranked 9th in men (ASR: 44.4/100,000) and 15th in women
(ASR: 24.3/100,000) [5]. Colorectal cancer is the 2nd most
common cancer and 2nd commonest cause of cancer death in
Croatia [6]. Screening programs have been initiated on
National level in 2005, their full impact is still expected [7].
It has been estimated that over 30% of the variation in
colorectal cancer susceptibility is attributable to genetic factors
and majority of this seems to be due to multiple low risk
mutations [8]. To date, genome-wide association studies
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(GWAS) have identified 20 independent single nucleotide
polymorphisms (SNP) associated with colorectal cancer risk
[9-15].
It is known that the contribution of risk alleles to CRC risk
may vary between populations, for example due to allele
frequencies or specific linkage disequilibrium (LD) structure, or
because of particular genetic and environmental backgrounds
may modify the effect of the variants [16,17]. Understanding
differential effects in different populations may aid in
uncovering disease mechanism, and is important for the
translation of results to risk prediction in different populations.
The role of risk loci in colorectal cancer occurrence is largely
unexplored in Croatian population. In this paper, we set out to
investigate the role of four risk loci: rs4939827, rs10795668,
rs3802842 and rs16892766, on colorectal cancer risk in
Croatian population.
Methods
In the period from November 2008 to July 2009, a total of
338 colorectal cancer cases were recruited at departments of
surgery in two hospitals in Zagreb, Croatia. Although both are
located in Zagreb, these tertiary care hospitals attract patients
from across the country. Data on age at diagnosis, sex, tumour
histology and TNM stage were collected from CRC patients’
medical records and histopathology reports. Eighteen cases
were excluded from the analysis because diagnosis of
adenocarcinoma was not confirmed in histopathology report.
Metastasis identified intraoperatively or confirmed by imaging
methods were considered in evaluating disease progression.
Colorectal cancer cases were classified into stages according
to American Joint Committee on Cancer (AJCC) 7th edition
[18].
594 controls were selected from the ‘10,001 Dalmatians’
study, an ongoing genetic study in Croatia. This study includes
approximately three thousand individuals from the general
population of Split and from Vis and Korčula Islands in Croatia.
Controls were picked randomly, but with constrains regarding
age (+/- 5 years) and sex. Participants with personal history of
malignant disease were excluded from the control group.
Informed consent was obtained in writing from all
participants. The study was approved by the appropriate ethics
committees: the Ethics Committee of the University of Split
Medical School and Ethical Board of the University Hospital
Center Sestre milosrdnice.
At recruitment, peripheral blood sample was collected from
each subject and stored in EDTA coated vials. DNA was
extracted using standard procedures. In cases, variants
rs4939827, rs3802842, rs10795668 and rs16892766 were
genotyped using the TaqMan SNP Genotyping Assay. DNA
samples of controls were genotyped according to the
manufacturer’s instructions on Illumina Infinium SNP bead
microarrays (HumanHap300v1 or HumanCNV370-Quad).
Genotypes were determined using Illumina BeadStudio
software. Samples with a call rate below 97% were excluded.
Variants rs4939827 and rs3802842 and were represented on
the array and directly genotyped while rs10795668 and
rs16892766 were imputed. Imputation with reference to
HapMap CEU build 36 release 22 was performed using the
software MACH v1.0.15 after exclusion of SNP with MAF
<0.01, call rate <98% and HWE deviation p <10-6. Imputation
quality was 99% for rs10795668 and 98% for rs16892766.
Statistical Analysis
R software was used for analyses and R package GenABEL
was used for manipulating genetic data. χ2 test was used to
assess deviations from Hardy-Weinberg equilibrium. Age- and
sex-adjusted logistic regression analysis of CRC on allele
dosage (0, 1 or 2) was performed to assess the association
between four variants and colorectal cancer risk, under the
assumption of additive genetic model. Multiple testing
corrected P-value of P<0.0125 was considered representative
of statistical significance.
Results
A total of 320 (40% female) colorectal cancer cases and 594
(45% female) controls were included in this study. Mean age of
cases was 68.91 ± 10.08 y and of controls 66.12 ± 10.23 y.
Where tumour site was known, 56% of cases had colon cancer
and 44% had rectal or rectosygmoid tumour. Majority of cases
had disease in AJCC stages 2 and 3 (33% and 42%,
respectively). The characteristics of cases and controls are
detailed in Table 1.
Table 1. Characteristics of study population.
Variable Cases Controls
Number 320 (35%) 594 (65%)
Sex    
 Male 192 (60%) 324 (55%)
 Female 128 (40%) 270 (45%)
Age (years) 68.91 ± 10.08 66.12 ± 10.23
AJCC stage   
 I 56 (18%)  
 II 107 (33%)  
 III 134 (42%)  
 IV 21 (7%)  
 Unknown 2 (1%)  
 Total 320 (100%)  
Site    
 Colon 128 (40%)  
 rectosigmoid 7 (2%)  
 Rectum 94 (29%)  
 Unknown 91 (28%)  
 Total 320 (100%)  
Tumour size (cm) 5.0 ± 2.1  
 range (cm) 1-13  
Lymph nodes a   
 Sampled 15 (IQR: 14-19)  
 positive (%) 5 (IQR: 0-27)  
 positive (%, if 0 positive) 27 (IQR: 12-49)  
a. only cases with 12 or more lymph nodes sampled are included (N=156)
doi: 10.1371/journal.pone.0074042.t001
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All four variants conformed to the Hardy-Weinberg
equilibrium. In the entire sample (cases and controls) allele
frequency of T allele was 49.55%. In the logistic regression
model we found statistically significant association between
rs4939827 and CRC risk. The proportion of each of the
rs4939827 genotypes CC, CT and TT was 29%, 49% and 22%
in controls, respectively, and 21%, 47% and 32% in cases,
respectively. C allele was associated with a decreased risk,
odds ratio (OR) was 0.70 (95% CI: 0.57-0.85, P=3.5E-4).
Compared to TT homozygotes, risk was significantly reduced
by 34% in heterozygotes (OR=0.66, 95% CI: 0.47-0.92) and by
52% in CC homozygotes (OR=0.48, 95% CI: 0.33-0.72) (Table
2).
We next investigated the association between genotypes at
rs4939827, rs10795668, rs3802842 and rs16892766 and
tumour characteristics in an age and sex adjusted multivariate
linear regression model. No statistically significant association
was observed between selected variants and the following
tumour characteristics: AJCC stage, tumour grade, tumour size
or proportion of positive lymph nodes.
Discussion
In this study we found a significant association between
SMAD7 variant rs4939827 (18q21.1) and risk of colorectal
cancer in Croatian population. Compared to CC homozygotes,
risk was increased by 58% in heterozygotes (CT) and by 111%
in TT homozygotes.
The mechanism by which rs4939827 may influence
colorectal cancer involves inhibitory role of the SMAD7 protein
in the transforming growth factor beta (TGF-β) signalling
pathway [19,20]. TGF-β pathway regulates growth inhibition
and apoptosis and plays an important role in cancer initiation
and progressions [21,22].
In a comprehensive meta-analysis, we have previously
shown a very high credibility of the association between
rs4939827 and colorectal cancer [23]. However, in the previous
studies reported effect sizes were in most part weaker than
what we observed in Croatian population (ORper T=1.43). In a
combined meta-analysis [23], found an OR of 1.15 (95% CI:
1.08-1.23) and [24] found an OR of 1.18 (95% CI: 1.14-1.22).
As is reflected in overlapping confidence intervals, effect size
that we observe is not significantly different than what has been
previously reported. However, evidence of heterogeneity
between studies exists, and further larger studies are needed
to determine whether different risk estimates arise due to
random variation, or they reflect true population differences.
Studies where higher OR was reported include [9] who found
an OR of 1.37 (95%CI: 1.18-1.58) and [24] who found an OR of
1.57 (95% CI: 1.27-1.94) in 641 cases and 1037 controls from
China [9,10,24] report a high OR in an Israeli population
(OR=1.48; 95% CI: 1.33-1.65), but this may be, in part, due to
poor genotyping quality (genotyping failed in >20% of samples
and significant deviation from HWE was reported) [10]. The
replication of GWAS signals in different ethnic groups is
important as the frequency of the susceptible alleles at these
loci may vary between world populations [25]. The allele
frequencies we observed at rs4939827 locus in Croatian
population (T allele frequency, AFT=49.6%) were very similar to
that of the other European populations (CEU-AFT=44.7%;
EUR-AFT =52.9%), while prevalence of T allele is less frequent
in Asian and African populations (ASN-AFT=25.9%; AFR-AFT
=28.7%) (http://www.ensembl.org).
Moreover, replication studies can help identify population-
specific environmental factors that modify the effect of risk loci.
The relatively strong association between SMAD7 variant and
CRC reported here, if verified, may be due to the particular
genetic and/or environmental background specific for Croatian
population. This finding warrants larger studies to explore the
association further, as understanding the origin of the stronger
effect in this population may help uncover mechanisms of
colorectal cancer occurrence and progression, and may
subsequently lead to translation of findings into more accurate
risk prediction and better informed prevention should the
interaction with environment be found.
We failed to replicate associations between CRC risk and
rs10795668, rs16892766 and rs3802842; however, this is may
be due to the relatively small sample size [26-29] Similarly,
Table 2. The association between variants rs10795668, rs16892766, rs3802842 and rs4939827 and colorectal cancer in
Croatian population.
SNP genotypes cases controls effect allele OR 95% CI: P
rs10795668        
 AA/AG/GG 34/123/148 48/276/270 A 0.99 0.80-1.23 0.93
 unknown 15 0     
rs16892766        
 AA/AC/CC 248/42/1 502/86/6 A 1.06 0.73-1.54 0.74
 unknown 29 0     
rs3802842        
 AA/AC/CC 132/122/17 280/252/62 A 1.15 0.92-1.45 0.23
 unknown 49 0     
rs4939827        
 CC/CT/TT 63/143/96 172/291/131 C 0.7 0.57-0.85 3.5x10-04
 unknown 18 0     
doi: 10.1371/journal.pone.0074042.t002
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small sample size may be the reason why we fail to detect
significant associations between rs4939827, rs10795668,
rs3802842 and rs16892766 and tumour characteristics (AJCC
stage, tumour grade, tumour size or proportion of positive
lymph nodes). With the exception of rs1321311, rs3824999
and rs5934683 [15], the role of other known CRC risk loci on
susceptibility to CRC in Croatian population is otherwise
unexplored [9-14].
Limitations of the study include relatively small sample size
that may have contributed to our limited power to detect weak
associations. Secondly, while controls were mainly from Split
and islands of Vis and Korčula, cases were sampled from
tertiary hospitals in Zagreb. However, this is not a major issue
for this study: firstly, Croatian population is small and
homogeneous; secondly, Zagreb and Split represent urban
centres that attract immigration from other regions in Croatia,
and lastly, patients would seek treatment in Zagreb due to
perceived superiority of health care irrespective of their
residence.
In conclusion, a common variant rs4939827 is associated
with colorectal cancer risk in Croatian population.
Understanding differential effects in different populations may
aid in uncovering disease mechanism and is important for the
translation of results to risk prediction in different populations.
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